Societal savings in patients with advanced non-squamous non-small-cell lung cancer receiving bevacizumab-based versus non-bevacizumab-based treatments in France, Germany, Italy, and Spain

References

• SantMAareleidTBerrinoFEUROCARE-3: survival of cancer patients diagnosed 1990–1994 – results and commentaryAnn Oncol200314 Suppl 5v61v11814684501
   PubMed Web of Science ®Google Scholar
• FerlayJSinHRBrayFFormanDMathersCParkinDMGLOBOCAN 2008 v1.2, Cancer incidence and mortality worldwideIARC CancerBase No 10Lyon, FranceInternational Agency for Research on Cancer2010 Available from: http://globocan.iarc.frAccessed on August 7, 2012
   Google Scholar
• WilkingNJönssonBA Pan-European Comparison Regarding Patient Access to Cancer DrugsStockholm, SwedenKarolinska Institutet2005
   Google Scholar
• GrallaRJThatcherNQuality-of-life assessment in advanced lung cancer: considerations for evaluation in patients receiving chemotherapyLung Cancer200446 Suppl 2S41S4715698531
   PubMed Web of Science ®Google Scholar
• HeyesAClinical trial experience with functional assessment of cancer therapy-lung in conventional and targeted non-small-cell lung cancer therapySemin Oncol200431162215206078
   PubMed Web of Science ®Google Scholar
• JohnLDQuality of life in patients receiving radiation therapy for non-small-cell lung cancerOncol Nurs Forum20012880781311421140
   PubMedGoogle Scholar
• MontazeriAGillisCRMcEwenJQuality of life in patients with lung cancer: a review of literature from 1970 to 1995Chest19981134674819498968
   PubMed Web of Science ®Google Scholar
• PaccagnellaAFavarettoAOnigaFCisplatin versus carboplatin in combination with mitomycin and vinblastine in advanced non small cell lung cancer. A multicenter, randomized phase III trialLung Cancer200443839114698542
   PubMed Web of Science ®Google Scholar
• StoutRBarberPBurtPClinical and quality of life outcomes in the first United Kingdom randomized trial of endobronchial brachytherapy (intraluminal radiotherapy) vs external beam radiotherapy in the palliative treatment of inoperable non-small-cell lung cancerRadiother Oncol20005632332710974381
   PubMed Web of Science ®Google Scholar
• Van PuttenJWBaasPCodringtonHActivity of single-agent gemcitabine as second-line treatment after previous chemotherapy or radiotherapy in advanced non-small-cell lung cancerLung Cancer20013328929811551424
   PubMed Web of Science ®Google Scholar
• WachtersFMVan PuttenJWKramerHFirst-line gemcitabine with cisplatin or epirubicin in advanced non-small-cell lung cancer: a Phase III trialBr J Cancer2003891192119914520444
   PubMed Web of Science ®Google Scholar
• WagnerLRueMFischMNeuropsychiatric symptoms during cancer treatment: an examination of quality of life data from two ECOG lung cancer trialsProc Am Soc Clin Oncol200221Abstract 1426
   Google Scholar
• CollinsLGHainesCPerkelREnckRELung cancer: diagnosis and managementAm Fam Physician200775566317225705
   PubMed Web of Science ®Google Scholar
• European Medicines AgencyEuropean Public Assessment Report (EPAR) summary for the public – Avastin® (bevacizumab) Available from: http://www.emea.europa.eu/docs/en_GB/document_library/EPAR_-_Summary_for_the_public/human/000582/WC500029260.pdfAccessed on August 7, 2011
   Google Scholar
• ReckMvon PawelJZatloukalPPhase III trial of cisplatin plus gemcitabine with either placebo or bevacizumab as first-line therapy for nonsquamous non-small-cell lung cancer: AVAilJ Clin Oncol2009271227123419188680
   PubMed Web of Science ®Google Scholar
• SandlerAGrayRPerryMCPaclitaxel-carboplatin alone or with bevacizumab for non-small-cell lung cancerN Engl J Med20063552542255017167137
   PubMed Web of Science ®Google Scholar
• National Institute for Health and Clinical ExcellenceThe diagnosis and treatment of lung cancer: methods evidence and guidance. 2005CG24 Lung cancer: Full guideline2005 Available from: http://www.nice.org.uk/nicemedia/pdf/cg024fullguideline.pdfAccessed August 8, 2012
   Google Scholar
• SchillerJHHarringtonDBelaniCPComparison of four chemotherapy regimens for advanced non-small-cell lung cancerN Engl J Med2002346929811784875
   PubMed Web of Science ®Google Scholar
• CrinoLDansinEGarridoPSafety and efficacy of first-line bevacizumab-based therapy in advanced non-squamous non-small-cell lung cancer (SAiL, MO19390): a phase 4 studyLancet Oncol20101173374020650686
   PubMed Web of Science ®Google Scholar
• LuceBRMauskopfJSloanFAOstermannJParamoreLCThe return on investment in health care: from 1980 to 2000Value Health2006914615616689708
   PubMed Web of Science ®Google Scholar
• Canadian Agency for Drugs and Technologies in HealthGuidelines for the Economic Evaluation of Health Technologies3rd ed2006 Available from: http://www.cadth.ca/media/pdf/186_EconomicGuidelines_e.pdfAccessed August 7, 2012
   Google Scholar
• National Institute for Health and Clinical ExcellenceGuide to the methods of technology appraisal2008 Available from: http://www.nice.org.uk/media/B52/A7/TAMethodsGuideUpdatedJune2008.pdfAccessed August 7, 2012
   Google Scholar
• Swedish Pharmaceutical Benefits BoardGeneral guidelines for economic evaluation from the Pharmaceutical Benefits Board2003 Available from: http://www.tlv.se/Accessed August 7, 2012
   Google Scholar
• GoldMRSiegelJERussellLBWeinsteinMCCost-Effectiveness in Health and MedicineOxford, UKOxford University Press1996
   Google Scholar
• JohannessonMJönssonBJönssonLKobeltGZethraeusLWhy Should Economic Evaluations of Medical Innovations Have a Societal Perspective? Report No 51London, UKOffice of Health Economics2009
   Google Scholar
• PerroneFBenelliGLopatrielloSCost of non-small-cell lung cancer in Italy. Results of the longitudinal study ALCEA (Advanced Lung Cancer Economic Assessment)J Clin Oncol200422Suppl 14SAbstr 8265
   Google Scholar
• StanisicSBischoffHGHeigenerDFSocietal cost savings through bevacizumab-based treatment in non-small-cell lung cancer (NSCLC)Lung Cancer201069 Suppl 1S24S3020727459
   PubMedGoogle Scholar
• SandlerAYiJDahlbergSTreatment outcomes by tumor histology in Eastern Cooperative Group Study E4599 of bevacizumab with paclitaxel/carboplatin for advanced non-small-cell lung cancerJ Thorac Oncol201051416142320686429
   PubMed Web of Science ®Google Scholar
• RocheReal life data in metastatic non-small-cell lung cancer (final pooled results of a pilot study in Germany and France focusing on Avastin)2011 (Data on file)
   Google Scholar
• EurostatEurostat – tables, graphs and maps interface – employment rate by gender (total)Eurostat2011 Available from: http://epp.eurostat.ec.europa.eu/tgm/refreshTableAction.do;jsessionid=9ea7d07d30e638c532abb5a84095bdbcc9c4e5677df0.e34OaN8PchaTby0Lc3aNchuMb3qNe0?tab=table&plugin=1&pcode=tsiem010&language=enAccessed September 29, 2011
   Google Scholar
• Institute National du CancerAnalyse Économique des Coûts du Cancer en France: Impact sur la qualié de la vie, prévention, dépistage, soins, rechercheNational Cancer Institute: Economic Analysis of Cost of Cancer in France: Impact on the quality of life, prevention, screening, cancer care and researchBoulogne-Billancourt, FranceInstitut National du Cancer2007 French
   Google Scholar
• TanAFreemanDHFreemanJLZhangDDDayalHPhilipsBUThe cost of cancer in Texas, 2007Publication No 10-13121Austin, TXTexas Cancer Registry, Texas Department of Health Care Service2009
   Google Scholar
• WilliamsAWelfare economics and health status measurementvan der GaagJPerlmanMHealth, Economics and Health EconomicsAmsterdam, The NetherlandsNorth Holland Publishing1981
   Google Scholar
• BischoffHGChouaidCVergnenegreAPCN8 real life outcomes in 1st line non-squamous non-small-cell lung cancer (NSCLC): a pilot study in France and Germany analysing bevacizumab-based versus non-bevacizumab-based treatmentsValue Health201114A156
   Web of Science ®Google Scholar
• BradleyCJBednarekHLEmployment patterns of long-term cancer survivorsPsychooncology20021118819812112479
   PubMed Web of Science ®Google Scholar
• GridelliCFerraraCGuerrieroCInformal caregiving burden in advanced non-small-cell lung cancer: the HABIT studyJ Thorac Oncol2007247548017545841
   PubMed Web of Science ®Google Scholar
• JacouletPDepierreAMoroDLong-term survivors of small-cell lung cancer (SCLC): a French multicenter study. Groupe d’Oncologie de Langue FrancaiseAnn Oncol19978100910149402175
   PubMed Web of Science ®Google Scholar
• Taskila-BrandtTMartikainenRVirtanenSVPukkalaEHietanenPLindbohmMLThe impact of education and occupation on the employment status of cancer survivorsEur J Cancer2004402488249315519524
   PubMed Web of Science ®Google Scholar
• van LoonAJBrugJGoldbohmRAvan den BrandtPABurgJDifferences in cancer incidence and mortality among socio-economic groupsScand J Soc Med1995231101207676217
   PubMedGoogle Scholar
• van LoonAJGoldbohmRAKantIJSwaenGMKremerAMvan den BrandtPASocioeconomic status and lung cancer incidence in men in The Netherlands: is there a role for occupational exposure?J Epidemiol Community Health19975124299135784
   PubMed Web of Science ®Google Scholar